Previous studies have shown that levels of CXCL-8 are elevated in patients with chronic hepatitis C virus (HCV) infection and are highest in nonresponders to interferon (IFN) therapy and that CXCL-8 inhibits IFN antiviral action. CXCL-8 expression involves AU-rich elements (AREs) in 3 untranslated regions that regulate mRNA stability. CXCL-8 mRNA stability was, therefore, investigated in the context of HCV replication in 4 replicon cell lines, Huh7 and Huh7.5 cells, and primary human fetal hepatocytes.
Chronic infection results in a spectrum of liver disease, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Substantial in vitro and clinical data indicate that HCV proteins interact with many cellular proteins and pathways [4] . The NS5A protein uses several mechanisms to inhibit cellular antiviral defenses. NS5A binds to and inhibits dimer formation of the interferon (IFN)-induced double-stranded RNA-dependent protein kinase PKR and prevents autoactivation of PKR kinase activity [5] . The PKR-binding domain on NS5A includes the IFN sensitivity-determining region (ISDR), in which mutations are associated with response to therapy [6] . NS5A-targeted inhibition of PKR requires the ISDR plus 26 additional amino acids and provides molecular insights into how NS5A inhibits the IFN system. However, analysis of the full-length NS5A gene revealed correlations between response to therapy and mutations in the PKR-binding domain and in a region downstream of the ISDR [7] , suggesting that NS5A may use other mechanisms to inhibit the IFN system. A, Establishment of a standard curve. Serial dilutions of a plasmid containing CXCL-8 cDNA were added to 384-well plates in triplicate and run through the real-time RT-PCR described in Materials and Methods. Ct, the cycle threshold when the PCR products were first detected. The experiment was repeated 12 times with similar results. Error bars represent SDs. B, Specificity of the assay. In the leftmost lanes, CXCL-8 mRNA was quantitated on total cellular RNA from BB7 replicon cells treated for 0, 2, 4, and 6 h with 15 ng/mL tumor necrosis factor (TNF)-a. In the rightmost 5 lanes, 10 ng of BB7 and pGEM plasmid DNA or 10 ng of tRNA, polyI:C, or mouse cell RNA (derived from a mouse embryo fibroblast cell line) was added to the CXCL-8 RT-PCR.
NS5A also induces interleukin 8 (CXCL-8) mRNA and protein expression and partial inhibition of the antiviral actions of IFN [8] [9] [10] [11] , which is consistent with the finding that recombinant CXCL-8 inhibits the antiviral actions of IFN against certain viruses [12] . That CXCL-8 is a highly proinflammatory chemokine [13] suggests that modulation of CXCL-8 expression during HCV infection may also affect viral replication and pathogenesis. Although the mechanisms by which CXCL-8 inhibits IFN are under investigation, it has been demonstrated that serum levels of CXCL-8 are elevated in patients with chronic HCV infection, and serum levels of CXCL-8 are also higher in patients who fail to respond to antiviral therapy than in patients who respond [14, 15] .
Our previous data suggested that NS5A induction of CXCL-8 involved transcriptional activation of the CXCL-8 promoter [8] . However, induction of CXCL-8 by viruses and cytokines is not solely mediated by transcriptional activation. For example, tumor necrosis factor (TNF)-a-and adenovirus-mediated induction of CXCL-8 involves mRNA stabilization [16] [17] [18] . Mechanistically, both TNF-a and CXCL-8 belong to a Figure 2 . Characteristics of CXCL-8 mRNA in liver cell cultures. Cell cultures were treated with tumor necrosis factor (TNF)-a for 2 h, followed by actinomycin D (ActD). RNA was harvested at 0, 2, 4, 6, 12, and 24 h after the addition of ActD, and CXCL-8 was quantitated by use of realtime reverse-transcription polymerase chain reaction. Cell lines are indicated on the Y-axis. A, Basal levels of CXCL-8 mRNA. Data are expressed as copies of CXCL-8 mRNA per 10 ng of total cellular RNA. B, TNF-a induction of CXCL-8 mRNA. The data reflect the fold increase in CXCL-8 mRNA copy no. after 2 h of TNF-a stimulation, compared with that in cells that did not receive stimulation. C, CXCL-8 mRNA half-life calculated using the decay model described in Materials and Methods. Experiments were repeated 2-4 times for each cell line. Hep, primary human fetal hepatocytes.
unique gene family that is involved in diverse biological processes and contains regulatory AU-rich elements (AREs) in the 3 untranslated region (UTR) of the cellular mRNAs [19] . The AREs facilitate the binding of cellular proteins that either degrade or stabilize the mRNA transcripts [20] [21] [22] . Recently, it has been shown, using large-scale microarray analysis, that AREs with at least 2 pentameric AUUUA repeats are found in many cellular mRNAs with short half-lives, including TNF-a and CXCL-8 [23] . Moreover, TNF-a and CXCL-8 are coregulated ARE genes involved in many inflammatory and disease conditions, including viral hepatitis [24] .
In the present study, we investigated whether stabilization of CXCL-8 mRNA contributes to the induction of CXCL-8 during HCV replication in 4 independent HCV replicon liver cell lines. Induction and the half-lives of CXCL-8 mRNA were also determined in Huh7 cells, Huh7.5 cells (a highly permissive cell line for HCV), and primary human fetal hepatocytes. We also studied the effect of TNF-a, a potent inducer of CXCL-8, on the induction of ARE-containing cellular genes in Huh7 cells. The data indicate that, in certain stable HCV replicon cell lines, increases in the stability of CXCL-8 mRNA contribute to CXCL-8 induction and that, in Huh7 cells, TNF-a induces many ARE-containing cellular genes with similar patterns of regulation.
MATERIALS AND METHODS

Cells.
Human hepatoma Huh7 cells were grown in Dulbecco's MEM containing 10% fetal bovine serum, 1ϫ penicillin, streptomycin, fungizone, 10 mmol/L l-glutamine, and 1ϫ nonessential amino acids (all reagents were from Invitrogen). BB7 cells are Huh7 cells that support the replication of a subgenomic HCV replicon containing a S2204I adaptive mutation in the NS5A gene [25] . FL-Neo cells are a stable Huh7-derived cell line containing a genomic-length HCV replicon with the S2204I mutation in NS5A and a P1496L mutation in NS3. Huh7.5 cells are derived from Huh7 cells and are highly permissive for HCV RNA replication [26] . Huh7, Huh7.5, BB7, and FL-Neo cells were obtained from Apath. Subgenomic replicon cell lines 9-13 and 5-15-9-2-3 (hereafter referred to as "5-15 cells") containing different adaptive mutations (9-13, R2884G mutation in NS5B; 5-15, S2197P mutation in NS5A) [27] [28] [29] were provided by Ralf Bartenschlager (University of Heidelberg, Heidelberg, Germany). Primary fetal human hepatocytes were isolated and grown in chemically defined serum-free medium, as described elsewhere [30] , and were provided by Catherine Lazaro and Nelson Fausto. Primary hepatocyte cultures were analyzed within 2 days of isolation. Cells were maintained in humidified incubators at 37ЊC with 5% CO 2 .
Quantitation and half-life determination of CXCL-8 mRNA. CXCL-8 mRNA was quantitated by use of real-time reverse-transcription (RT) polymerase chain reaction (PCR), Figure 3 . Decay of CXCL-8 mRNA in human liver cell cultures. In the following panels, cells were treated with 10 ng/mL tumor necrosis factor (TNF)-a for 2 h, followed by 1 mg/mL actinomycin D (ActD) (A and C) or 1 mg/mL ActD plus 10 mg/mL cycloheximide (CHX) (B). Total cellular RNA was isolated at various times, and CXCL-8 mRNA was quantitated by use of real-time reverse-transcription polymerase chain reaction. A, CXCL-8 mRNA copy no. in Huh7 and BB7 replicon cells treated with TNFa then with ActD. B, CXCL-8 mRNA copy no. in Huh7, BB7, and 9-13 replicon cells treated with or without TNF-a followed by ActD plus CHX. C, CXCL-8 mRNA copy no. in BB7, 9-13, and 5-15 replicon cells treated with TNF-a then with ActD. Curves were fitted using the equation described in Materials and Methods.
using CXCL-8-specific primers. Total cellular RNA was isolated from liver cell cultures, using a commercial kit (Qiagen). We adopted stringent criteria to ensure that the input RNA (as cDNA) in each sample was similar during PCRs by using a sensitive fluoremetric method of RNA quantitation (Picogreen). The generation of a standard curve, on the basis of serial dilutions of fluorometrically quantified PCR products, has been shown to be very reliable and superior and to compensate for the use of housekeeping genes, which, themselves, can be variable [31, 32] . Ten nanograms of RNA was added to wells of a 384-well plate containing the EZ RT-PCR master mix (ABI). Samples were run on an ABI HT7900 real-time RT-PCR machine. CXCL-8 was amplified by forward (CXCL8-F, 5 -CTC TTG GCA GCC TTC CTG ATT) and reverse (CXCL8-R, 5 -TAT GCA CTG ACA TCT AAG TTC TTT AGC A) primers that corresponded to nucleotide positions 126-146 and 185-212 on CXCL-8 mRNA (GenBank accession number Y00787). The detection probe sequence (CXCL8-P; TET-CTT GGC AAA ACT GCA CCT TCA CAC AGA-TAMRA) was hybridized to nucleotide positions 155-181 of the CXCL-8 mRNA. The RT reaction consisted of 2 min at 50ЊC followed by 30 min at 60ЊC. The PCR consisted of an initial denaturation of 2 min at 95ЊC, then 45 cycles for 15 s at 95ЊC, followed by simultaneous annealing/extension for 1 min at 60ЊC. For each run, dilutions of BCGMS-CXCL-8 plasmid DNA (provided by Naofumi Mukaida, Kanazawa University, Kanazawa, Japan), ranging from 0 to 10 7 copies, were run in triplicate to generate a standard curve, which served as a reference for calculation of CXCL-8 copy number on the basis of the cycle threshold. Before use in the PCR, the CXCL-8 plasmid was precisely quantitated using the PicoGreen DNA quantitation kit (Invitrogen). The CXCL-8 copy number is reported as copies per 10 ng of total cellular RNA. Additional controls included reactions lacking template, which were always negative for HCV RNA.
To determine the half-life of CXCL-8 mRNA, a 1-phase exponential decay model was used. The model originally described the kinetics, such as the decay of radioactive isotopes, the elimination of drugs, and the dissociation of a ligand from a receptor. It is used to assess mRNA half-life because of the similar characteristics, in addition to its nonlinear regression modeling [33] . The model is particularly accurate in determining the half-life of decay situations, especially when the plateau is not zero as in many cases of mRNA decay. The equation is as follows:
where X is time, and Y may be either concentration or response. Y starts out equal to span + plateau and decreases to plateau, with a rate constant K. The half-life of the decay is 0.6932/K. Span and plateau are expressed in the same units as is the Yaxis-that is, copies of CXCL-8 mRNA. K is expressed in the Huh-7 hepatoma cells were treated with TNF-a (10 ng/mL for 2 h), whereas control cells were incubated in medium for 2 h (right column). Huh-7 cells were treated with TNF-a (10 ng/mL for 2 h) in the absence or presence of cycloheximide (CHX) pretreatment (10 mg/mL for 30 min) (middle column). Huh-7 cells were treated with TNF-a (10 ng/mL for 2 h) followed by either medium or 5 mg/mL actinomycin D (ActD) for 2 h (left column).
inverse of the units used by the X-axis-that is, hours after actinomycin D (ActD) treatment (GraphPad Prism Program). Microarray hybridization and analysis. The glass microarrays contained cDNA probes representing ARE cDNA clones whose identities were obtained from the ARE-containing mRNA database [19] . cDNA probes were generated by PCR amplification of plasmids, using M13 primers, and were spotted at least in duplicate on poly-l-lysine glass slides, using the GenMachine microarray robot. The microarrays were used for cohybridization with labeled cDNA generated from total RNA (20 mg) from 2 samples, using 2 fluorescent labels: Cy3 for control and Cy5 for experiment. We used a hybridization protocol that included the Genisphere kit (Genisphere), which used an approach in which the RT process included unlabeled nucleotides that could not incorporate any fluorescence into genomic DNA, thus eliminating the possibility of signal contribution from genomic DNA. The details of hybridization conditions using the Genisphere kit have been described elsewhere [34] .
Scanning of the cDNA microarray was performed with a ScanArray scanner that excites the Cy3 and Cy5 fluorophores at optimal wavelengths of 532 and 635 nm, respectively, with a spatial resolution of 10 mm. The intensity of green and red fluorescent signals from each spotted cDNA sequence on the microarray was calculated using an adaptive circle algorithm and the mean intensity of the pixels. Preprocessing, filtering of erroneous signals, and normalization procedures have been described elsewhere [34] . Intensity ratios (background subtracted normalized Cy5/intensity for experiment/background subtracted normalized intensity for Cy3 control) in duplicate spots on the array representing the same cDNA probe should be identical or, at least, very similar. Duplicates that gave different readings were excluded from further analysis. The intensity ratios from 2 cDNA samples measured in this way represented the relative expression profile of the ARE genes in the 2 starting RNA samples. The normalized florescence ratios between experiment and control samples were log 2 transformed. K-means clustering and Treeview programs were used to analyze the data (http://www.microarrays.org/software/).
RESULTS
CXCL-8 mRNA expression in response to HCV and TNF-a in human liver cultures. To examine the effects of HCV replication on CXCL-8 mRNA expression and stability, we first established a real-time RT-PCR assay for the specific detection of CXCL-8 mRNA. The assay had a wide dynamic range and accurately quantitated 10-10 8 copies of CXCL-8 mRNA ( figure 1A ). The specificity of the assay was determined by measuring TNFa-induced CXCL-8 levels. We used TNF-a because it is a potent activator of CXCL-8 both in vitro and in vivo. BB7 replicon cells were treated with 15 ng/mL TNF-a, and RNA was extracted at various times. TNF-a induced rapid accumulation of CXCL-8 mRNA (∼35-fold) in BB7 cells, which peaked 2 h after stimulation and declined by 6 h after stimulation. The reaction was specific to CXCL-8 mRNA, since BB7 and pGEM plasmid DNA and polyI:C, tRNA, and mouse RNAs all failed to generate CXCL-8 amplification products (figure 1B). Figure 2A depicts the basal levels of CXCL-8 mRNA in the various cell lines tested. Primary human fetal hepatocytes had the highest basal levels, followed by BB7 cells and Huh7 cells. The remaining replicon lines-5-15, 9-13, FL-Neo, and Huh7.5 cells-had lower basal CXCL-8 mRNA levels. The relative levels of HCV replication in the different replicon cell lines are as follows: 9-13 1 5-15 1 BB7 1 FL-Neo. There was no evidence of a relationship between the basal levels of CXCL-8 mRNA and HCV replication in these stable HCV replicon cell lines. However, since the replicons have different adaptive mutations and express several HCV genes, it is difficult to infer quantitative correlations between induction of CXCL-8 expression and the various HCV proteins.
CXCL-8 mRNA characteristics in human liver cell cultures.
The CXCL-8 real-time RT-PCR assay was used to determine the half-life of CXCL-8 mRNA following TNF-a induction in Huh7 and HCV replicon cell lines. Cells were first treated for 2 h with TNF-a, followed by the addition of ActD to stop cellular transcription. RNA was then extracted from cells at various time points after the addition of ActD. In both Huh7 and BB7 replicon cell lines, CXCL-8 mRNA decreased between 2 and 4 h after the addition of ActD, which was followed by an increase in mRNA between 4 and 6 h after ActD treatment. Overall, using a 1-phase exponential decay model [33] , which takes into account global decay, we found that the half-life of CXCL-8 mRNA was increased in TNF-a-induced BB7 HCV replicon cells (5. [35, 36] .
When cells were treated with both ActD and the translational inhibitor cycloheximide (CHX), CXCL-8 mRNA did not decay in Huh7, BB7, or 9-13 replicon cells (figure 3B), which is consistent with the observation that inhibition of translation increases ARE mRNA stability [22] . Figure 3C depicts the decay profile of TNF-a-treated replicon cells (BB7, 9-13, and [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and shows that the subgenomic replicon lines 9-13 and 5-15 had CXCL-8 mRNA half-lives of 0.77 and 0.87 h, respectively (figure 2C). Figure 2B summarizes the data and demonstrates that TNF-a induction of CXCL-8 mRNA was similar in Huh7 cells and 9-13 replicon cells but was 24%-42% higher in the remaining 3 replicon cell lines and Huh7.5 cells, compared with that in Huh7 cells. Moreover, the half-life of CXCL-8 mRNA was increased in 2 subgenomic lines (BB7 and 5-15) and the FL-Neo genomic replicon cell line, compared with that in Huh7 cells ( figure 2C ). TNF-a induced only a modest increase in CXCL-8 mRNA levels in primary human fetal hepatocytes (figure 2B ), possibly because the basal level of CXCL-8 was so high ( figure 2A) .
Effect of TNF-a on ARE gene expression in Huh7 cells. TNF-a and CXCL-8 are part of a diverse group of cellular genes whose expression is regulated by mRNA stability [19, 23] . To investigate the global effects of TNF-a on liver cell mRNAs regulated by AREs, we analyzed cellular mRNAs from Huh-7 cell cultures treated with TNF-a. We performed cDNA microarray analysis using arrays consisting of 11500 cellular genes containing AREs in their 3 UTRs, in addition to housekeeping and control genes. [8] and others [49] , induce CXCL-8 via activation of the CXCL-8 promoter, leading to modest increases in CXCL-8 expression. In addition, tumor necrosis factor (TNF)-a may be produced [45] to further increase CXCL-8 expression during HCV replication. This involves transcriptional and posttranscriptional mechanisms-specifically, stabilization of CXCL-8 mRNA. Overall, the increased CXCL-8 expression in the context of chronic infection may contribute to increased viral pathogenesis and resistance to interferon (IFN) action, both in vitro and in vivo [8, 14] . However, TNF-a and CXCL-8 may exert protective effects when expressed for short durations, such as during acute infection. TNF-a also induces many genes that are known to share AU-rich elements (AREs) similar to those found in the 3 untranslated region (UTR) of CXCL-8 mRNA. The induction of these proinflammatory mediators may further contribute to HCV-induced hepatic inflammation, IFN resistance, and pathogenesis.
Huh-7 cells were treated with 10 ng/mL TNF-a for 2 h, and labeled cDNAs were hybridized to microarrays containing ARE genes. Expression ratios (TNF-a-treated cells vs. control untreated cells) of ARE genes were analyzed. In general, 158 genes were induced at least 1.5-fold by TNF-a. The vast majority (93%) were primary-response genes-that is, they did not require prior protein synthesis for induction. There were also 40 TNF-a-induced ARE genes (25% of the induced ARE genes) that were destabilized by ActD by at least 1.5-fold. Genes induced by 11.8-fold were log 2 transformed, mean centered, and viewed as a single cluster using Treeview. Figure 4 shows the top 50 genes induced by TNF-a that changed by у1.8-fold. In particular, TNF-a was able to induce CXCL-8 mRNA by a mean ‫ע‬ SE of 7.6-fold ‫ע‬ 1.5-fold ( ). In fact, CXCL-8 was one of the most highly n p 6 induced genes in the array of cellular ARE genes. Other chemokines that belong to the CXC superfamily sharing structures similar to CXCL-8 were also significantly induced by TNF-a. These genes included SCYB10 (also known as "CXCL10"; mean ‫ע‬ SE increase, 21-fold ‫ע‬ 4.6-fold; ), GRO1 (mean ‫ע‬ SE n p 5 increase, 14-fold ‫-8.1ע‬fold;
), GRO3 (mean increase, 1.8-n p 11 fold), and SCYD1 (also called "fractalkine"; mean ‫ע‬ SE increase, 3-fold ‫ע‬ 0.5-fold). We also found several genes involved in regulation of inflammatory responses that were strongly induced by TNF-a. These included TNFIP3 (mean ‫ע‬ SE increase, 8-fold ‫ע‬ 1.2-fold; ); NFkBAI, a negative regulator of NF-kB n p 11 (mean ‫ע‬ SE increase, 7-fold ‫ע‬ 0.7-fold; ); and MBL2 n p 5 (mean increase, 6-fold). Table 1 summarizes the fold differences for representative ARE-containing cellular mRNAs, for the different treatment conditions.
Effect of CHX on TNF-a-induced genes. CHX blocks protein synthesis and drives the expression of early response genes that do not require protein synthesis and also increases ARE mRNA stability [22] . To determine the effect of CHX on TNFa induction of ARE genes in human liver cells, Huh-7 cells were pretreated with 10 mg/mL CHX for 30 min, followed by treatment with TNF-a for 2 h. Control cells were incubated with TNF-a alone for 2 h. As is shown in figure 4 , the induction of many TNF-a-induced genes was independent of prior protein synthesis, and a subset of TNF-a-induced genes were induced to even higher levels by CHX treatment. The latter includes CXCL-8, which was induced 6-fold by TNF-a plus CHX, compared with treatment with TNF-a alone. Compared with no stimulus, TNF-a plus CHX induced CXCL-8 145-fold (table  1) . Other genes that were induced to higher levels in response to TNF-a plus CHX included cardiac ankyrin repeat protein (13-fold), GRO3 (11-fold), TGFB-inducible early growth response (TIEG; 7-fold), JUNB, TNFIP3 (4.4-fold), GRO1 (3.6-fold), and NFkBAI (3-fold), compared with TNF-a treatment alone. These data indicate that CHX treatment causes a superinduction of many ARE genes involved in inflammatory responses.
Effect of ActD on TNF-a induction of ARE genes. Increases in ARE mRNA expression by CHX could be due to inhibition of expression of proteins that negatively regulate mRNAs by targeting AREs. To evaluate this possibility and to distinguish from effects on transcription, cells were treated with ActD (5 mg/mL) for 2 h following TNF-a stimulation for 2 h. We hypothesized that, in cells treated with ActD and TNF-a, ARE mRNAs with short half-lives would be lower in abundance than mRNAs from control cells treated with TNF-a alone. Indeed, as is shown in table 1 and figure 4, CXCL-8 and many other TNF-a-induced genes-including GRO1, TNFAIP3, NFKBIA, MBL2, CSF1, JUNB, SOX9, TIEG, MEF2C, and GRO3-had decreases of more than one-half of their starting mRNA levels after 2 h of ActD treatment, compared with control cells. Cumulatively, the data suggest that, in Huh7 cells, the induction of ARE mRNAs by TNF-a requires both transcriptional induction and message stabilization.
DISCUSSION
In this article, we have examined the regulation of CXCL-8 in human liver cell cultures in the context of in vitro HCV replication and TNF-a stimulation. We found evidence supporting both transcriptional and mRNA stability mechanisms for induction of cellular genes in response to HCV replication and TNF-a treatment. Figure 5 summarizes the findings of the present study. Overall, the data suggest that some HCV replicon cell lines induce CXCL-8 by both transcriptional and posttranscriptional mechanisms. Posttranscriptional mechanisms, such as mRNA stabilization, may significantly contribute to TNF-ainduced increases in CXCL-8 production in the presence of HCV replication. Studies are currently in progress to determine whether TNF-a acts as an endogenous inducer of CXCL-8 in this model.
The majority of the replicon lines and Huh7.5 cells had higher TNF-a inducibility of CXCL-8 mRNA, compared with Huh7 cells. Several explanations may account for this finding. First, several HCV proteins have been shown to modulate NF-kB and activator protein 1 [8, [37] [38] [39] , 2 transcription factors central to CXCL-8 induction by TNF-a. Second, the stable replicon cell lines may have acquired genetic or epigenetic alterations during adaptation to continuous HCV replication and/or selection in G418-containing media [26, 40] , which could affect the regulation of CXCL-8 expression. Further studies on CXCL-8 mRNA stability in transient replicon assays or other HCV infection systems will be required to reconcile these issues.
Using cDNA microarrays, we found that many ARE-containing cellular genes, including CXCL-8, were induced by TNF-a. Many of the chemokines and other molecules that were induced by TNF-a have functions in the inflammatory response. Some of the molecules included the IFN-g-induced IP-10 protein, GRO1, GRO3, and SCYD1 [41] . Another ARE gene, NFkBAI, which mediates negative feedback control of TNF-induced genes by inhibiting NFkB activation [42, 43] , was also highly induced by TNF-a. TNF-a also induced the MBL2 gene 6-fold. This gene codes for soluble mannose-binding lectin (protein C), which is involved in antimicrobial defense as an opsonin [44] . Thus, DNA microarray analysis was invaluable for delineating the complex cellular responses to a single cytokine.
The increase in CXCL-8 mRNA stability in HCV replicon cells, particularly with concurrent treatment with TNF-a, and the regulation of ARE mRNAs by CHX and ActD (as shown by ARE cDNA microarray experiments) suggest a role for AREbinding proteins. ARE-binding proteins destabilize or stabilize ARE mRNAs, depending on the RNA-binding protein, its localization status, and stimulus-induced phosphorylation. For example, TNF-a, which is induced by HCV [45] , may modulate the activity of the RNA-binding protein HuR, which stabilizes CXCL-8 and other ARE mRNAs [46] . We are currently evaluating the relationships between RNA-binding proteins, CXCL-8, and other ARE mRNAs during HCV replication.
The findings here lend support to a role for TNF-a in modulation of HCV replication by increasing CXCL-8 via stabilization of CXCL-8 mRNA. TNF-a is a proinflammatory cytokine that is strongly associated with HCV-induced hepatitis [45] . In addition to these deleterious effects, TNF-a also encodes protective functions. Indeed, TNF-a displays antiviral activity against several different viruses [47, 48] , suggesting that an initial proinflammatory response mediated by TNF-a is beneficial to the host. The duality of the function of TNF-a further suggests that proinflammatory chemokines, such as CXCL-8, may display both antiviral and proviral effects, depending on whether the infection is acute or chronic and on the cellular context.
